NDC Package 80070-230-41 Anbesol Maximum Strength

Benzocaine Solution Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
80070-230-41
Package Description:
1 BOTTLE in 1 BLISTER PACK / 12 mL in 1 BOTTLE
Product Code:
Proprietary Name:
Anbesol Maximum Strength
Non-Proprietary Name:
Benzocaine
Substance Name:
Benzocaine
Usage Information:
Adults and children 2 years of age and overwipe liquid on with cotton, or cotton swab, or fingertip, apply to the affected area up to 4 times daily or as directed by a doctor/dentistchildren under 12 years of ageadult supervision should be given in the use of this productchildren under 2 years of agedo not usefor denture irritation:apply thin layer to the affected areado not reinsert dental work until irritation/pain is relievedrinse mouth well before reinserting
11-Digit NDC Billing Format:
80070023041
NDC to RxNorm Crosswalk:
  • RxCUI: 308657 - benzocaine 20 % Mucous Membrane Topical Solution
  • RxCUI: 308657 - benzocaine 200 MG/ML Mucous Membrane Topical Solution
  • RxCUI: 608897 - Anbesol 20 % Mucous Membrane Topical Solution
  • RxCUI: 608897 - benzocaine 200 MG/ML Mucous Membrane Topical Solution [Anbesol]
  • RxCUI: 608897 - Anbesol 200 MG/ML Mucous Membrane Topical Solution
  • Product Type:
    Human Otc Drug
    Labeler Name:
    Foundation Consumer Brands
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    part356
    Marketing Category:
    OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
    Start Marketing Date:
    09-15-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 80070-230-41?

    The NDC Packaged Code 80070-230-41 is assigned to a package of 1 bottle in 1 blister pack / 12 ml in 1 bottle of Anbesol Maximum Strength, a human over the counter drug labeled by Foundation Consumer Brands. The product's dosage form is solution and is administered via topical form.

    Is NDC 80070-230 included in the NDC Directory?

    Yes, Anbesol Maximum Strength with product code 80070-230 is active and included in the NDC Directory. The product was first marketed by Foundation Consumer Brands on September 15, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 80070-230-41?

    The 11-digit format is 80070023041. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-280070-230-415-4-280070-0230-41